High-density lipoprotein mimetics: promises and challenges

被引:27
作者
Sviridov, Dmitri [1 ]
Remaley, Alan T. [2 ]
机构
[1] Baker IDI Heart & Diabet Inst, Lab Lipoprot & Atherosclerosis, Melbourne, Vic 3004, Australia
[2] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
apolipoproteins; atherosclerosis; cholesterolmetabolism; lipoprotein metabolism; peptides; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; PEPTIDE; 4F; ANTIINFLAMMATORY PROPERTIES; CORONARY ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; AMPHIPATHIC PEPTIDES; PLASMA-CLEARANCE; LESION FORMATION; OXIDIZED LIPIDS;
D O I
10.1042/BJ20150832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of lipoprotein mimetics was developed and extensively tested in the last three decades. Most lipoprotein mimetics were designed to recreate one or several functions of high-density lipoprotein (HDL) in the context of cardiovascular disease; however, the application of this approach is much broader. Lipoprotein mimetics should not just be seen as a set of compounds aimed at replenishing a deficiency or dysfunctionality of individual elements of lipoprotein metabolism but rather as a designer concept with remarkable flexibility and numerous applications in medicine and biology. In the present review, we discuss the fundamental design principles used to create lipoprotein mimetics, mechanisms of their action, medical indications and efficacy in animal models and human studies.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [31] High-density lipoprotein heterogeneity and function in reverse cholesterol transport
    Rothblat, George H.
    Phillips, Michael C.
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (03) : 229 - 238
  • [32] Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications
    Cho, Kyung-Hyun
    BMB REPORTS, 2009, 42 (07) : 393 - 400
  • [33] Inflammation, high-density lipoprotein and cardiovascular dysfunction
    Haas, Michael J.
    Mooradian, Arshag D.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (03) : 265 - 272
  • [34] High-density lipoprotein infusion therapy: A review
    Brewer Jr, Bryan
    Schaefer, Ernst J.
    Foldyna, Borek
    Ghoshhajra, Brian B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (03) : e374 - e383
  • [35] High-density lipoprotein metabolism and the human embryo
    Fujimoto, Victor Y.
    Kane, John P.
    Ishida, Brian Y.
    Bloom, Michael S.
    Browne, Richard W.
    HUMAN REPRODUCTION UPDATE, 2010, 16 (01) : 20 - 38
  • [36] Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
    Smith, Jonathan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 382 - 388
  • [37] High-density lipoprotein therapeutics and cardiovascular prevention
    Fazio, Sergio
    Linton, MacRae F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 411 - 419
  • [38] Speciated High-Density Lipoprotein Biogenesis and Functionality
    C. Rosales
    W. S. Davidson
    B. K. Gillard
    A. M. Gotto
    H. J. Pownall
    Current Atherosclerosis Reports, 2016, 18
  • [39] High-density lipoprotein metabolism and endothelial function
    Lowenstein, Charles J.
    Cameron, Scott J.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) : 166 - 170
  • [40] High-density lipoprotein synthesis and metabolism (Review)
    Zhou, Lingyan
    Li, Congcong
    Gao, Ling
    Wang, Aihong
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4015 - 4021